Back to Search

DOUGLAS SPRIGGS, MD

MD

Interventional Cardiology Physician

NPI: 1811986698IndividualAccepts Medicare

Specialties, Licenses & Credentials

Cardiovascular Disease Physician

Internal Medicine — Cardiovascular Disease

Code: 207RC0000X

ME60174(FL)
Interventional Cardiology PhysicianPrimary

Internal Medicine — Interventional Cardiology

Code: 207RI0011X

ME60174(FL)

CMS Specialties

PrimaryINTERVENTIONAL CARDIOLOGY

Additional

CARDIOVASCULAR DISEASE (CARDIOLOGY)

Education

UNIVERSITY OF TOLEDO COLLEGE OF MEDICINE

Class of 1984

Research & Publications (20)

CA-125 change after chemotherapy in prediction of treatment outcome among advanced mucinous and clear cell epithelial ovarian cancers: a Gynecologic Oncology Group study.
PMID 19195045·Cancer·2009
6-review
Epothilones: better or more of the same?
PMID 19451426·J Clin Oncol·2009
6-review
The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma: a Gynecologic Oncology Group study.
PMID 19156927·Cancer·2009
8-other
Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study.
PMID 19135708·Gynecol Oncol·2009
3-trial
Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission.
PMID 18451240·Clin Cancer Res·2008
3-trial
A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer.
PMID 18554700·Gynecol Oncol·2008
3-trial
A comprehensive comparison of the continual reassessment method to the standard 3 + 3 dose escalation scheme in Phase I dose-finding studies.
PMID 18827039·Clin Trials·2008
4-observational
Phase I study of the novel epothilone analog ixabepilone (BMS-247550) in patients with advanced solid tumors and lymphomas.
PMID 17261851·J Clin Oncol·2007
3-trial
A phase I trial of BMS-247550 (NSC# 710428) and gemcitabine in patients with advanced solid tumors.
PMID 17364235·Invest New Drugs·2007
3-trial
Duration of second or greater complete clinical remission in ovarian cancer: exploring potential endpoints for clinical trials.
PMID 17614127·Gynecol Oncol·2007
4-observational

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

Contact & Hours

Address
455 PINELLAS ST, SUITE 400
CLEARWATER, FL 33756

Quick Facts

NPI
1811986698
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
1
Years in Practice
42
Publications
20

Are you this provider?

Claim Your Profile